Archive

Archive for the ‘Stem Cell Technology’ Category

Aastrom Biosciences (ASTM), More Dilution on the Horizon

February 4th, 2011 No comments

New proxy to increase number of authorized shares to raise additional capital or acquire another company  Read more…

The iPSC-ESC Gap

February 3rd, 2011 No comments

Stem cells created from mature cells, called induced pluripotent stem cells, Read more…

UCSF receives $20M Stem Cell Building Gift

February 3rd, 2011 No comments

Ray and Dagmar Dolby donated $20M to the University of California, San Francisco (UCSF) to provide funding for a stem cell building. Read more…

Lin 28 Gene enhances Stem Cell Growth and Survivability

February 2nd, 2011 No comments

Key gene, Lin28 enhances hESC development,  stem cell creation, growth and survival. Read more…

Osiris Therapeutics (OSIR) trends despite Downgrade

February 2nd, 2011 No comments

OSIR trends upwards despite WBB Securities’ downgraded from a “sell” rating to a “sell short” rating Read more…

Pluristem (PSTI) closes Public Offering

February 2nd, 2011 No comments

PSTI (TASE:PLTR) closed its $38M public offering of 11,000,000 units, Read more…

New Legislation filed re Patent Laws

February 1st, 2011 No comments

The USPTO rules governing patent rights are on the verge of new legislation. Read more…

Athersys (ATHX), Research Note, Jason Kolbert, National Securities

February 1st, 2011 No comments

Athersys (ATHX) raised capital last week, gross proceeds of $13.1M, selling 4.3M shares with 0.3 warrants per share at a strike of $3.55. Read more…

IPierian and Kyoto University Patent Deal for iPSC Technology

February 1st, 2011 No comments

iPierian and Kyoto University ink a series of intellectual property deals. Read more…

Cytori Therapeutics (CYTX), SST to promote PureGraft System

January 31st, 2011 No comments

Sound Surgical Technologies LLC (SST) has signed a sales agreement for the PureGraft System in the US. Read more…